University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Robert K. Kerlan, M.D.

Chief, Interventional Radiology

Dr. Robert K. Kerlan is chief of Interventional Radiology at UCSF Medical Center. He is particularly interested in the management of liver disease, including biliary disease, portal hypertension and hepatic malignancy. In his research, he is working to devleop new procedures to diagnose and treat patients with problems related to living donor organ transplants.

Kerlan earned a medical degree at the University of Southern California in Los Angeles. He completed a radiology residency at UCSF and served as chief radiology resident. He is a member of several professional organizations, including his election as a fellow of the Society of Cardiovascular and Interventional Radiology. He is a professor of clinical radiology at UCSF.

Conditions & Treatments

Clinics

Comprehensive Fibroid Center
2356 Sutter St., Sixth Floor
San Francisco, CA 94143-1648
Phone: (415) 885-7788
Fax: (415) 353-9550

Hours: Monday to Friday
8 a.m. – 5 p.m.

Interventional Radiology
505 Parnassus Ave., Room M-361
San Francisco, CA 94143
Phone: (415) 353-1300
Appointments: (415) 353-2573
Billing: 415) 514-8888
Fax: (415) 353-8570

Hours: Monday to Friday
8:30 a.m. – 5 p.m.

More about Robert K. Kerlan

Education

University of Southern California School of Medicine 1977

Residencies

UCSF Medical Center, Diagnostic Radiology 1981

Selected Research and Publications

  1. Kerlan RK, Laberge JM. Intranodal lymphangiography: coming soon to a hospital near you. J Vasc Interv Radiol. 2012 May; 23(5):617.
  2. Durack JC, Wang JH, Schneider DB, Kerlan RK. Vena cava filter scaffold to prevent migration of embolic materials in the treatment of a massive renal arteriovenous malformation. J Vasc Interv Radiol. 2012 Mar; 23(3):413-6.
  3. Kwan SW, Kerlan RK. Intrapleural migration of a percutaneous transhepatic hemodialysis catheter. J Vasc Access. 2012 Jan; 13(1):115-7.
  4. Guy J, Kelley RK, Roberts J, Kerlan R, Yao F, Terrault N. Multidisciplinary management of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2012 Apr; 10(4):354-62.
  5. Villalta JD, Sorensen MD, Durack JC, Kerlan RK, Stoller ML. Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents. J Urol. 2011 Sep; 186(3):921-7.
  6. Farrelly C, Fidelman N, Durack JC, Hagiwara E, Kerlan RK. Transcatheter arterial embolization of spontaneous life-threatening extraperitoneal hemorrhage. J Vasc Interv Radiol. 2011 Oct; 22(10):1396-402.
  7. Kwan SW, Fidelman N, Durack JC, Roberts JP, Kerlan RK. Rex shunt preoperative imaging: diagnostic capability of imaging modalities. PLoS One. 2011; 6(7):e22222.
  8. Fidelman N, Kerlan RK, Laberge JM, Gordon RL. Accuracy of percutaneous transhepatic cholangiography in predicting the location and nature of major bile duct injuries. J Vasc Interv Radiol. 2011 Jun; 22(6):884-92.
  9. Durack JC, Westphalen AC, Kekulawela S, Bhanu SB, Avrin DE, Gordon RL, Kerlan RK. Perforation of the IVC: Rule Rather Than Exception After Longer Indwelling Times for the Günther Tulip and Celect Retrievable Filters. Cardiovasc Intervent Radiol. 2012 Apr; 35(2):299-308.
  10. Durack J, Bass N, Teitel D, Kerlan R, Roberts J. Endovascular closure of a portocaval shunt after left lobe liver transplantation using an Amplatzer muscular ventricular septal occluder device. Liver Transpl. 2011 Feb; 17(2):211-4.
  11. Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation. 2010 Dec 27; 90(12):1595-601.
  12. Tan JH, Fidelman N, Durack JC, Hays SR, Leard LL, Laberge JM, Kerlan RK, Golden JA, Gordon RL. Management of recurrent airway strictures in lung transplant recipients using AERO covered stents. J Vasc Interv Radiol. 2010 Dec; 21(12):1900-4.
  13. Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, Gores G, Kerlan R, Merle P, O'Neil B, Poon R, Schwartz L, Tepper J, Yao F, Haller D, Mooney M, Venook A. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2010 Sep 1; 28(25):3994-4005.
  14. Roberts JP, Venook A, Kerlan R, Yao F. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation. Liver Transpl. 2010 Aug; 16(8):925-9.
  15. Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant. 2010 Aug; 10(8):1870-80.
  16. Bhagat N, Fidelman N, Durack JC, Collins J, Gordon RL, LaBerge JM, Kerlan RK. Complications associated with the percutaneous insertion of fiducial markers in the thorax. Cardiovasc Intervent Radiol. 2010 Dec; 33(6):1186-91.
  17. Kwan SW, Bhargavan M, Kerlan RK, Sunshine JH. Effect of advanced imaging technology on how biopsies are done and who does them. Radiology. 2010 Sep; 256(3):751-8.
  18. Kwan SW, Kerlan RK, Sunshine JH. Utilization of interventional oncology treatments in the United States. J Vasc Interv Radiol. 2010 Jul; 21(7):1054-60.
  19. Kerlan RK, LaBerge JM. Fistula first, stent graft second. N Engl J Med. 2010 Feb 11; 362(6):550-2.
  20. Mission JF, Kerlan RK, Tan JH, Fang MC. Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients. J Gen Intern Med. 2010 Apr; 25(4):321-5.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.